STAT3 and cancer: Several studies have reported an association between inflammation and STAT3 activation, and persistent or dysregulated STAT3 signaling can lead to many diseases, including chronic inflammation, fibrosis, and cancer, and STAT3 inhibitors are optimistic as treatments for these diseases, but caution is needed to avoid toxicity16.